Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2024

Jul 2, 2024

3091_iss_2024-07-02_a438f6f1-c0cd-43ea-a6d2-a06f611d7986.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Nordnet AB (publ)

Instrument

Instrument Aktie SE0009414576
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Buy
Date 01/07/2024
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 11,311,871
Directly held voting rights 0
Indirectly held voting rights 11,311,871
Percentage
Directly held shares 5.25678 %
Directly held voting rights 0 %
Indirectly held voting rights 5.34445 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.34445 % 11,311,871
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.34445 % 11,311,871
Chain
of
controlling
Voting rights % Voting rights Company
companies
10,999,316 5.19678 Nordnet Pensionsförsäkring AB

312,555 0.14767 Nordnet Livsforsikring AS Group total holdings Voting rights 11,311,871

Percentage of voting rights 5.34445

Published

02/07/2024 16:01

Contact Name Niklas Matses Phone 0733854156 Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25